KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) FCF Payout Ratio (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 45.42%
Dec 31, 2025 35.88%
Sep 30, 2025 -26.45%
Jun 30, 2025 -71.48%
Mar 31, 2025 412.98%
Dec 31, 2024 -23.04%
Sep 30, 2024 -60.93%
Jun 30, 2024 88.00%
Mar 31, 2024 24.79%
Dec 31, 2023 61.66%
Sep 30, 2023 -16.44%
Jun 30, 2023 -35.46%
Mar 31, 2023 90.67%
Dec 31, 2022 2.99%
Sep 30, 2022 -34.60%
Jun 30, 2022 -3.12%
Mar 31, 2022 12.43%
Dec 31, 2021 57.83%
Sep 30, 2021 -39.04%
Jun 30, 2021 -0.64%
Mar 31, 2021 7.83%
Dec 31, 2020 22.75%
Sep 30, 2020 -37.82%
Jun 30, 2020 25.93%
Mar 31, 2020 -6.78%
Dec 31, 2019 41.78%
Sep 30, 2019 -46.66%
Jun 30, 2019 24.19%
Mar 31, 2019 22.94%
Dec 31, 2018 28.88%
Sep 30, 2018 -38.09%
Jun 30, 2018 23.59%
Mar 31, 2018 4.97%
Dec 31, 2017 104.68%
Sep 30, 2017 -1.09%
Jun 30, 2017 -1,870.92%
Mar 31, 2017 -21.74%
Dec 31, 2016 -6.03%
Sep 30, 2016 34.12%
Jun 30, 2016 12.68%
Mar 31, 2016 -0.36%
Dec 31, 2015 10.24%
Sep 30, 2015 -12.02%
Jun 30, 2015 -12.72%
Mar 31, 2015 159.20%
Dec 31, 2014 -320.03%
Sep 30, 2014 -1.93%
Jun 30, 2014 -67.54%
Mar 31, 2014 124.64%
Dec 31, 2013 52.43%
Sep 30, 2013 15.56%
Jun 30, 2013 -42.52%